CRON / Cronos Group exits US hemp CBD business to boost cash flow

If you're a true contrarian, you should look at cannabis stocks in 2023. A premier player in this abandoned stock sector is Cronos (NASDAQ: CRON ). more_horizontal

Unsurprisingly, the current year has been depressing for cannabis stocks. Regulatory headwinds continue to play spoilsport and making stock prediction more_horizontal

Cannabis stocks have navigated an extended period of uncertainty and financial depression thanks to regulatory headwinds. Further, most cannabis compa more_horizontal

Marijuana stock investors are keeping focused on the future of the cannabis industry. Right now even with an increase in volatile trading, the industr more_horizontal

The U.S.-listed shares of Cronos Group Inc. CRON, -3.24% CRON, -3.56% climbed 2.5% in premarket trading Monday, after the Toronto-based cannabis compa more_horizontal

The global buzz around medical cannabis stocks just got a whole lot louder. The corridors of the U.S. health sector are abuzz with the federal Health more_horizontal

De facto U.S. marijuana legalization on the Federal level could be coming sooner than many think. A top official at the Department of Health and Human more_horizontal

The continued lack of legalization of marijuana at the federal level is preventing greater growth across the industry. That could change by the end of more_horizontal